Stock CEMI CHEMBIO DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages Chembio Diagnostics, Inc. OTC Bulletin Board

Equities

CEMI

US1635722093

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Chembio Diagnostics, Inc. acquired FastPack® diagnostics business from Qualigen Therapeutics, Inc. for $5.8 million.
CHEMBIO DIAGNOSTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc.(NasdaqCM:CEMI) dropped from NASDAQ Composite Index
Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023
CHEMBIO DIAGNOSTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Chembio’s CEO Letter to Stockholders
CHEMBIO DIAGNOSTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Biosynex : OPA prolongée sur Chembio Diagnostics
Biosynex Unit Extends Expiration Time of Tender Offer for Chembio Diagnostics Shares; Stock Rises
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt
CHEMBIO DIAGNOSTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CEMI Stock
  4. CEMI Stock
  5. News Chembio Diagnostics, Inc.
  6. Other languages